- ENDRA Life Sciences Announces Pricing of $8.0 Million Public Offering
- ENDRA Provides Update Following In-person Meeting with FDA
- ENDRA Life Sciences Reports First Quarter 2024 Financial Results and Provides a Business Update
- ENDRA Life Sciences to Report First Quarter 2024 Financial Results on May 14, 2024
- ENDRA Life Sciences Strengthens Intellectual Property with Issuance of Five New International Patents
More ▼
Key statistics
On Wednesday, ENDRA Life Sciences Inc (NDRA:NAQ) closed at 0.091, 31.50% above the 52 week low of 0.0692 set on Jun 04, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.0882 |
---|---|
High | 0.1024 |
Low | 0.0825 |
Bid | 0.091 |
Offer | 0.0923 |
Previous close | 0.0892 |
Average volume | 12.75m |
---|---|
Shares outstanding | 70.27m |
Free float | 67.53m |
P/E (TTM) | -- |
Market cap | 6.39m USD |
EPS (TTM) | -1.26 USD |
Data delayed at least 15 minutes, as of Jul 03 2024 17:59 BST.
More ▼